Fireside Chat with Chad Robins, CEO of Adaptive Biotechnologies at the GeekWire Summit

Adaptive Biotechnologies CEO Chad Robins, whose Seattle company completed one of the most spectacular IPOs of the year by raising $300 million in June, discusses the transformative technologies that may finally push the industry out of the pen-and-paper era in the Health Tech Track at the 2019 GeekWire Summit. Moderated by Luke Timmerman of The Timmerman Report.